Results 31 to 40 of about 4,753,656 (310)
Capecitabine and temozolomide for metastatic intermediate to high-grade pancreatic neuroendocrine neoplasm: a single center experience [PDF]
The Korean Journal of Internal Medicine, 2022 Background/Aims The combination of capecitabine and temozolomide (CAPTEM) is one of the treatment options for metastatic pancreatic neuroendocrine neoplasms (pNENs).
Sathathone Douangprachanh +11 more
doaj +1 more source
Annals of Hepatology, 2016 Obesity prevalence is rapidly increasing worldwide. It is associated with huge economic and health costs due to its clinical consequences, which includes increased incidence of type 2 diabetes, cardiovascular diseases, and development of different malignancies.
Saitta C., Pollicino T., Raimondo G.
openaire +5 more sources
Journal of Hematology & Oncology, 2016 Background Our previous study reported that microRNA-26a (miR-26a) inhibited tumor progression by inhibiting tumor angiogenesis and intratumoral macrophage infiltration in hepatocellular carcinoma (HCC). The direct roles of miR-26a on tumor cell invasion
De-Ning Ma +13 more
doaj +1 more source
Cancer Medicine, 2023 Background SQSTM1/p62 is a selective autophagy receptor that regulates multiple signaling pathways participating in the initiation and progression of tumors.
Jiafeng Chen +15 more
doaj +1 more source
Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab [PDF]
Journal of Liver Cancer, 2023 Background/Aim Radiotherapy (RT) is an effective local treatment for hepatocellular carcinoma (HCC). However, whether additional RT is safe and effective in patients with advanced HCC receiving atezolizumab plus bevacizumab remains unclear.
Tae Hyun Kim +4 more
doaj +1 more source
Treatment of Liver Cancer [PDF]
Cold Spring Harbor Perspectives in Medicine, 2015 Primary liver cancer, mostly hepatocellular carcinoma, remains a difficult-to-treat cancer. Incidence of liver cancer varies geographically and parallels with the geographic prevalence of viral hepatitis. A number of staging systems have been developed, reflecting the heterogeneity of primary liver cancer, regional preferences, and regional variations ...
Chun-Yu, Liu +2 more
openaire +2 more sources
Liver Development, Regeneration, and Carcinogenesis [PDF]
, 2010 The identification of putative liver stem cells has brought closer the previously separate fields of liver development, regeneration, and carcinogenesis. Significant overlaps in the regulation of these processes are now being described.
Ross, James A +7 more
core +1 more source
Hepatocellular carcinoma in Korea: an analysis of the 2016-2018 Korean Nationwide Cancer Registry [PDF]
Journal of Liver CancerBackgrounds/Aims Hepatocellular carcinoma (HCC) is the sixth most common cancer and second leading cause of cancer-related deaths in South Korea. This study evaluated the characteristics of Korean patients newly diagnosed with HCC in 2016-2018.
Jihyun An +16 more
doaj +1 more source
Decreased expression of breast cancer resistance protein in the duodenum in patients with obstructive cholestasis [PDF]
, 2006 Background/Aims: The expression of transporters involved in bile acid homeostasis is differentially regulated during obstructive cholestasis. Since the drug efflux transporter breast cancer resistance protein (BCRP) is known to transport bile acids, we ...
Beuers, Ulrich +7 more
core +1 more source
Cancer Cell International, 2019 Background Oxaliplatin-based chemotherapy is widely used to treat hepatocellular carcinoma (HCC). Recent studies suggested that therapeutic resistance of tumors was affected by tumor microenvironment (TME).
Xiu-Tao Fu +9 more
doaj +1 more source